
Humanity is a science-backed health and longevity company that offers a software application designed to monitor and help users slow down or reverse their rate of aging. The app integrates data from wearables, manual inputs, and blood/genetic markers to provide a personalized 'Humanity Score' and insights into how lifestyle choices impact biological age. They offer solutions for individuals through their app and for businesses via Humanity Teams, aiming to reduce absenteeism, boost productivity, and foster a healthy culture. The company's approach leverages AI and machine learning, with a strong emphasis on privacy and scientific validation, including research published in Nature.

Humanity is a science-backed health and longevity company that offers a software application designed to monitor and help users slow down or reverse their rate of aging. The app integrates data from wearables, manual inputs, and blood/genetic markers to provide a personalized 'Humanity Score' and insights into how lifestyle choices impact biological age. They offer solutions for individuals through their app and for businesses via Humanity Teams, aiming to reduce absenteeism, boost productivity, and foster a healthy culture. The company's approach leverages AI and machine learning, with a strong emphasis on privacy and scientific validation, including research published in Nature.
What they do: Consumer health app that estimates and monitors biological age and rate of aging
Product: iOS app (Humanity Score) integrating wearables, manual inputs, and biomarkers
Founders: Pete (Peter) Ward (Co‑Founder & CEO) and Michael Geer (Co‑Founder & CSO)
Team size: Approximately 40 employees
Funding: $5M total disclosed seed funding (last reported Aug 2021)
Consumer health / longevity; biological age measurement and behavior-driven healthspan extension
Healthtech / Longevity
2500000.00 USD
Reported $2.5M seed extension in Aug 2021 bringing disclosed total to $5M
2500000.00 USD
Earlier seed funding reported in Aug 2020 contributing to disclosed total of $5M
“Angel and early-stage health/consumer-tech investors including named individuals and micro VCs”